Literature DB >> 15302479

Grade 4 cystocele repair using four-defect repair and porcine xenograft acellular matrix (Pelvicol): outcome measures using SEAPI.

Line Leboeuf1, Ruth Ann Miles, Sandy S Kim, Angelo E Gousse.   

Abstract

OBJECTIVES: To determine the efficacy of grade 4 cystocele repair using the four-defect repair (FDR) or modified FDR with porcine xenograft matrix (FDR+Pelvicol).
METHODS: During a 4-year period, 45 women underwent grade 4 cystocele repair. Of the 45 patients, 43 (95.5%) were available for follow-up. The mean age was 65 years. Patients presented with the following problems: grade 4 cystocele in 43 (100.0%), stress urinary incontinence in 24 (55.8%), urge urinary incontinence in 26 (60.4%), and obstructive voiding symptoms in 26 (60.4%). Patients were evaluated using the stress, emptying, anatomic, protection, and instability (SEAPI) test. We performed FDR in the first consecutive 24 (55.8%) and FDR+Pelvicol in the remaining 19 (44.2%) patients. Cystocele repair was accompanied by other transvaginal repair in 38 (88.3%) of the 43 patients.
RESULTS: The mean follow-up time was 15 months. A comparison of the preoperative and postoperative SEAPI scores of 0, representing the absence of complaints, revealed a statistically significant improvement in all the SEAPI domains using McNemar's test. Cystocele recurred in 3 patients (6.9%), all in the Pelvicol subgroup. Two patients (4.7%) had postoperative urinary retention. De novo urge incontinence occurred in 2 patients (11.7%). No infection, erosion, fistula, or vaginal stenosis have been reported.
CONCLUSIONS: Grade 4 cystocele repair using FDR or FDR+Pelvicol are two effective methods of cystocele repair. Although cystocele failures occurred exclusively in the Pelvicol+FDR subgroup, their small number and asymptomatic presentation did not result in statistical or clinical significance at this point. Both techniques are simple, efficacious, and well tolerated by patients. Follow-up is ongoing to evaluate the durability of the techniques.

Entities:  

Mesh:

Year:  2004        PMID: 15302479     DOI: 10.1016/j.urology.2004.03.044

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Evaluating the porcine dermis graft InteXen in three-compartment transvaginal pelvic organ prolapse repair.

Authors:  Rajeev Ramanah; Julian Mairot; Marie-Caroline Clement; Bernard Parratte; Robert Maillet; Didier Riethmuller
Journal:  Int Urogynecol J       Date:  2010-04-28       Impact factor: 2.894

Review 2.  Xenograft use in reconstructive pelvic surgery: a review of the literature.

Authors:  Emanuel C Trabuco; Christopher J Klingele; John B Gebhart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-01-17

3.  Anterior compartment prolapse repair with a hybrid biosynthetic mesh implant technique.

Authors:  Jose E Robles; Jorge Rioja; Abel Saiz; Xavier Brugarolas; David Rosell; J Javier Zudaire; Jose M Berian
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-01-24

4.  Biomesh (Pelvicol) erosion following repair of anterior vaginal wall prolapse.

Authors:  Martin Rudnicki
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-10-10

5.  Incidence and management of vaginal extrusion of acellular porcine dermis after incontinence and prolapse surgery.

Authors:  Alex Gomelsky; Rashel M Haverkorn; Walter J Simoneaux; Seth Bilello; William S Kubricht
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-01

Review 6.  Anterior vaginal compartment surgery.

Authors:  Christopher Maher
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

Review 7.  The use of graft materials in anterior compartment pelvic reconstruction.

Authors:  J Sean Begley; Kathleen C Kobashi
Journal:  Curr Urol Rep       Date:  2004-10       Impact factor: 2.862

8.  A multicenter prospective trial evaluating fetal bovine dermal graft (Xenform® Matrix) for pelvic reconstructive surgery.

Authors:  Howard B Goldstein; Joseph Maccarone; Martin J Naughton; Oscar A Aguirre; Rakesh C Patel
Journal:  BMC Urol       Date:  2010-12-13       Impact factor: 2.264

9.  Use of grafts in pelvic reconstructive surgery.

Authors:  Myung Jae Jeon; Sang Wook Bai
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.